Oral and Phentermine


Oral Symptoms and Causes

It's important to take care of your mouth and teeth starting in childhood. If you don't, you could have problems with your teeth and gums - like cavities or even tooth loss.

Here's how to keep your mouth and teeth healthy:

  • Brush your teeth twice a day with a fluoride toothpaste
  • Clean between your teeth every day with floss or another type of between-the-teeth cleaner
  • Snack smart - limit sugary snacks
  • Don't smoke or chew tobacco
  • See your dentist or Oral health professional regularly

NIH: National Institute of Dental and Craniofacial Research

Check out the latest treatments for oral

oral treatment research studies

Phentermine clinical trials, surveys and public health registries

Find Drug Side Effect reports

Phentermine Side Effects

Pain (28)
Dyspnoea (27)
Anxiety (26)
Chest Pain (22)
Deep Vein Thrombosis (20)
Nausea (19)
Abdominal Pain (18)
Headache (16)
Blood Pressure Increased (16)
Abdominal Pain Upper (16)
Mitral Valve Incompetence (15)
Cholelithiasis (15)
Cholecystitis Chronic (14)
Pulmonary Embolism (14)
Injury (13)
Vomiting (13)
Ventricular Fibrillation (13)
Myocardial Infarction (13)
Loss Of Consciousness (12)
Dizziness (12)
Colitis Ischaemic (11)
Cardiac Arrest (11)
Gallbladder Disorder (10)
Fatigue (10)
Insomnia (10)
Cerebrovascular Accident (9)
Hypertension (9)
Arteriospasm Coronary (9)
Palpitations (8)
Confusional State (8)
Chest Discomfort (7)
Convulsion (7)
Hypotension (7)
Emotional Distress (7)
Feeling Abnormal (7)
Asthenia (6)
Abnormal Behaviour (6)
Diarrhoea (6)
Pain In Extremity (6)
Hypoaesthesia (6)
Tricuspid Valve Incompetence (6)
Hypercoagulation (5)
Alanine Aminotransferase Increased (5)
Mental Disorder (5)
Heart Rate Increased (5)
Pneumomediastinum (5)
Ventricular Tachycardia (5)
Respiratory Arrest (5)
Pyrexia (5)
Migraine (5)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

Have not yet taken this medication however used Lamisel before and believe once used Lamisel should not be repeated as the toxins remain in the liver. If i now take Trisporal for the same problem (nail infection in my right big toe nail picked up

I experience a better mood, so much so infact that I am able to 'give up smoking' on the days I take trisporal.

I have not used the medication yet and am researching possible side effects as i have used Lamisel before and believe the toxins remain in the liver and Lamisel should not be repeated again ( used for 3 months) Has Trisporal got the same chemical c

I have taken the full 7day course of Trisporal (2 capsules at night) but there does not seem to be any difference? i wondered if there was maybe a delayed effect or is Trisporal supposed to work immediately?

What is trisporal?

What's Neoral side effects

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

48 years of age. I was diagnosed with urinary tract infection. Had one dose of monuril 3 gr. After 7 hours developed skin rash on the back, arms and neck, generally swelling of the face, specially below the eyes, Had oral antihistamine and went to

im 39 years old & i just want to know if it is still ok for me to take contraceptive oral pills?

&amp;gt;:o I was given Narcan in the recovery room by the PA. I went from 0-60 in pain and came up screaming after having a 90% rotator cuff tear fixed. It took them 20 minutes to get me oral medicine as well as a med pump before the pain was br

A few months back while I was still brushing with Sensodyne Pronamel, I developed a cavity (toothache) I believe that the toothpaste pushed this infection back up into my cheek. I was told by an Oral surgeon that the infection was heading towards my

After having extraction carrying on using colgate ever since I have dry lips dry mouth. Burning in face I have changed to oral b 2 days now does seem less not sure if it will heal also dentist keeps complianing at me she thinks I have an infection my

All this scares me. my doctor insists I get the injection. I have osteoporosis and she says it's a choice of falling and breaking a hip or the reclast. I can't take boniva or other oral meds like it because I've got gerd and they upset my chest.

Bad arm soreness. Cannot get the oral Welchol to dissolve in water. Help?

Can Flixonase nasal spray, or Seretide oral spray - Increase pottasium level, What action should i take.

From what I've heard from various doctors, it's normal to have an irregular period, missed period, or spotting throughout your cycle while on many forms of oral birth control. Some women (like myself) are actually put on certain forms to stop the men

Oral Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Clobetasol for Oral Graft-Versus-Host Disease
Condition: Oral Chronic Graft vs Host Disease
Interventions: Drug: Clobetasol Oral Rinse;   Procedure: Chronic GVHD organ staging;   Procedure: Assessment of Oral GVHD;   BehaviOral: Numeric rating scales for Oral pain;   BehaviOralOral Global Scale;   BehaviOral: Painometer (POM) Assessment;   BehaviOralOral Health Impact Profile-OHIP-14;   Procedure: Biopsy of buccal mucosa;   Procedure: Short ACTH stimulation test
Outcome Measures: To investigate efficacy of topical clobetasol 0.05% Oral rinse for Oral chronic graft-versus-host-disease (cGVHD) during a four-week treatment period as assessed by Oral Mucositis Rating Scale (OMRS).;   To assess the effect of topical clobetasol on Oral cGVHD related pain, sensitivity, and dryness.;   To evaluate the basic pharmacodynamics and pharmacokinetics of clobetasol mouth rinse in cGVHD patients.
2 Recruiting Phase II Clinical Trial of IntraOral Grafting of Human Tissue Engineered Oral Mucosa
Condition: Deficient Keratinized Oral Mucosa for Dental Rehabilitation With Endosseous Dental Implants
Interventions: Biological: EVPOME (autogenous ex vivo produced Oral mucosa equivalent);   Biological: POM (Palatal Oral mucosa)
Outcome Measures: Clinical increase in zone (width) of keratinized mucosa at grafted site;   Graft contracture
3 Not yet recruiting The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
Condition: Type 1 Diabetes
Interventions: Drug: Oral Cyclosporine A and Oral Lansoprazole;   Drug: Oral Placebos
Outcome Measures: Insulin Requirements among Recently Diagnosed Patients treated with Oral Cyclosporine and Oral Lansoprazole;   Glucagon stimulated C-peptide (area under the curve) and Hemoglobin A1C among Recent Onset Type 1 Diabetes Patients treated with Oral Cyclosporine and Lansoprazole
4 Not yet recruiting The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Oral Cyclosporine and Oral Lansoprazole;   Drug: Placebos
Outcome Measures: Insulin Requirements Among Patients Treated with Oral Cyclosporine and Oral Lansoprazole;   Glucagon C-peptide (under the curve) and Hemoglobin A1C levels among patients with existing type 1 diabetes treated with Cyclosporine and Lansoprazole
5 Not yet recruiting Stroke Oral healthCare pLan Evaluation
Conditions: Cerebrovascular Disorders;   Stroke;   Pneumonia;   Oral Hygiene
Intervention: Other: Enhanced complex Oral health care
Outcome Measures: Pneumonia;   Oral Health Impact Profile;   Dental plaque;   Denture plaque;   Antibiotics prescribed;   Death
6 Unknown  Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Condition: Oral Mucositis
Intervention: Drug: IZN-6N4
Outcome Measures: Proportion of WHO score 3-4 Oral Mucositis at a Cumulative Radiation Dosage of 50 Gy in the active and Placebo Groups;   Incidence of grade 2-3-4 Oral Mucositis as measured by the WHO scale at increasing increments of cumulative radiation exposure
7 Recruiting Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: IV cefazolin plus Oral probenecid and placebo cephalexin;   Drug: Oral cephalexin and saline IV plus probenecid placebo
Outcome Measure: The proportion of patients failing therapy after 72 hours of antibiotic treatment with Oral cephalexin or intravenous cefazolin plus Oral probenecid.
8 Recruiting Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
Condition: Oral Contraceptive
Interventions: Drug: Oral Contraceptive: Ortho-Novum® 1/35;   Drug: Oral Contraceptive: Ovcon® 35;   Drug: Oral Contraceptive: Microgestin Fe® 1/20
Outcome Measure: To measure breast cell proliferation levels between the three Oral contraceptive dose groups.
9 Unknown  Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
Conditions: Seborrhea;   Seborrheic Dermatitis;   Quality of Life
Interventions: Drug: Oral isotretinoin;   Drug: salicylic acid and ciclopirox olamine
Outcome Measures: Sebum secretion rate;   sebum secretion rate;   Oral isotretinoin side effects;   Oral isotretinoin side effects
10 Recruiting Caphosol in Oral Mucositis Due to Targeted Therapy
Conditions: Oral Mucositis;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Gastrointestinal Stromal Tumors
Interventions: Other: supersaturated calcium-phosphate rinse;   Other: sodium chloride 0.9 %
Outcome Measures: Assess the severity of patient-reported Oral adverse events as determined by the change in the VHNSS2.0 score 3 times a week, from onset of Oral adverse events during the active Oral rinse period with Caphosol versus NaCl 0.9%;   Determine the decrease in grade of Oral adverse events as measured by the NCI-CTCAE v4.0 once a week, during a 2 week treatment with Caphosol Oral rinse versus NaCl 0.9% Oral rinse, 4 times daily, 2 minutes with 30 ml solution;   Assess the incidence of dose delay or dose interruption, dose reduction and discontinue treatment owing to Oral burden due to targeted anticancer therapy during the active Oral rinse period, once a week;   To correlate the incidence of Oral mucositis with: grade ≥ 2 hand-foot skin reaction (HFSR), and grade ≥ 2 papulopustular eruption (PPE) with all agents as measured by the NCI-CTCAE v4.0, during the active Oral rinse period, once a week;   Side Study: Explorative analysis of polymorphism in genes encoding for pharmacokinetic and pharmacodynamic variables related to the pharmacodynamics of the TKIs
11 Unknown  Elective Versus Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity
Condition: Oral Cancer
Intervention: Procedure: Elective Vs Therapeutic neck dissection in early Oral cancer
Outcome Measures: Survival;   Does Ultrasound examination have any role in the routine initial workup of a node negative patient?;   How are patients ideally followed up -does sonography have a role or is clinical examination sufficient.;   Is assessment of tumor thickness by the surgeon at the time of initial surgery accurate -Is there a correlation;   Identify histological prognostic factors in the primary that may help identify a sub-set of patients at an increased
12 Recruiting Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.
Conditions: Carcinogenesis;   Oral Cancer
Outcome Measure: Carcinogenesis of Gα12
13 Recruiting Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
Conditions: Carcinogenesis;   Oral Cancer
Outcome Measure: Carcinogenesis of SOX-9
14 Recruiting Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Oral Insulin
Outcome Measures: Effect of treatment with Oral insulin versus placebo in individuals in the primary stratum ( ICA+ confirmed or GAD65 and ICA512 positive on the same sample with confirmation of at least one of these autoantibodies).;   Secondary analyses will be done to assess the effects of Oral insulin versus placebo in other categories of subjects defined using different combinations of autoantibodies and metabolic status.
15 Recruiting Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Vinorelbine-Docetaxel;   Drug: Vinorelbine
Outcome Measures: Time To Disease Progression of patients who are treated with Vinorelbine-Docetaxel followed by maintenance Oral Vinorelbine vs patients treated with Vinorelbine-Docetaxel without maintenance treatment;   Overall Response Rate;   Duration of Response;   Quality of Life;   Number and percentage of participants with Adverse Events;   3-Y Overall Survival
16 Not yet recruiting The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma
Conditions: Oral Potentially Malignant Disorder;   Oral Cancer;   Malignant Disorder;   p62/SQSTM1
Outcome Measure: The study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma
17 Recruiting Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin
Outcome Measures: Early clinical response rate in the Intent to Treat (ITT) population;   Early clinical response rate in the microITT population;   Clinical success rates in the ITT and Clincally Evaluable (CE) populations
18 Unknown  Comparison of Oral and Intravenous Ibuprofen for PDA Treatment in Premature Infants
Conditions: Extremely Premature Infants;   PDA;   Oral Ibuprofen;   IV Ibuprofen
Interventions: Drug: iv ibuprofen;   Drug: Oral ibuprofen
Outcome Measures: The primary outcome is to ascertain whether Oral ibuprofen is effective and safe in inducing PDA closure in extremely premature infants.;   A secondary objective is to compare the complications between infants treated with Oral ibuprofen and those treated with IV ibuprofen.
19 Recruiting Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin
Conditions: Recurrent Clostridium Difficile Infection;   Laboratory Confirmed Clostridium Difficile Infection
Interventions: Drug: Vancomycin;   Biological: Fecal Transplant
Outcome Measure: A Randomized Controlled Trial of Oral Vancomycin Followed by Fecal Transplantation versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection.
20 Not yet recruiting Investigating a New Way of Giving Medicine to Newborn and Preterm Babies
Conditions: Hypophosphataemia;   Osteopenia of Prematurity
Interventions: Drug: Oral thin film therapy (Potassium acid phosphate Oral thin films);   Drug: Standard therapy (Potassium acid phosphate Oral solution)
Outcome Measures: Serum phosphate;   Age-appropriateness